Cargando…
Pulmonary Complications after COVID-19
Coronavirus disease 2019 (COVID-19) is a threat to patients not only because of its acute course, but also because of various complications occurring in the following period, that is, more than 28 days after the onset of acute infection. The present study identified a total of 121 patients hospitali...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955291/ https://www.ncbi.nlm.nih.gov/pubmed/35330108 http://dx.doi.org/10.3390/life12030357 |
_version_ | 1784676301051789312 |
---|---|
author | Jakubec, Petr Fišerová, Kateřina Genzor, Samuel Kolář, Milan |
author_facet | Jakubec, Petr Fišerová, Kateřina Genzor, Samuel Kolář, Milan |
author_sort | Jakubec, Petr |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19) is a threat to patients not only because of its acute course, but also because of various complications occurring in the following period, that is, more than 28 days after the onset of acute infection. The present study identified a total of 121 patients hospitalized 29 or more days after the first positive result of a PCR test for SARS-CoV-2, of whom 98 patients were included in the study. Patients were divided into two groups by the time interval between the positive COVID-19 test result and hospitalization date. The time intervals were week 5–11 in an ongoing-COVID group (57.1% of patients) and 12 or more weeks in a post-COVID-group (42.9%). The most frequent reason for hospitalization was respiratory tract infection (58.2%). Pneumonia accounted for 77.2% of these cases. Other reasons for hospitalization were interstitial lung disease (22.4%), pulmonary embolism (8.2%), and sarcoidosis (6.1%). The study group was further divided according to the causes of hospitalization into subgroups with infections and other causes. In the group with infectious diseases, there was a shorter time period between PCR positivity and hospitalization and there were significantly more frequent non-respiratory complications. In the entire sample, the in-hospital mortality was 5.1%. |
format | Online Article Text |
id | pubmed-8955291 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89552912022-03-26 Pulmonary Complications after COVID-19 Jakubec, Petr Fišerová, Kateřina Genzor, Samuel Kolář, Milan Life (Basel) Article Coronavirus disease 2019 (COVID-19) is a threat to patients not only because of its acute course, but also because of various complications occurring in the following period, that is, more than 28 days after the onset of acute infection. The present study identified a total of 121 patients hospitalized 29 or more days after the first positive result of a PCR test for SARS-CoV-2, of whom 98 patients were included in the study. Patients were divided into two groups by the time interval between the positive COVID-19 test result and hospitalization date. The time intervals were week 5–11 in an ongoing-COVID group (57.1% of patients) and 12 or more weeks in a post-COVID-group (42.9%). The most frequent reason for hospitalization was respiratory tract infection (58.2%). Pneumonia accounted for 77.2% of these cases. Other reasons for hospitalization were interstitial lung disease (22.4%), pulmonary embolism (8.2%), and sarcoidosis (6.1%). The study group was further divided according to the causes of hospitalization into subgroups with infections and other causes. In the group with infectious diseases, there was a shorter time period between PCR positivity and hospitalization and there were significantly more frequent non-respiratory complications. In the entire sample, the in-hospital mortality was 5.1%. MDPI 2022-02-28 /pmc/articles/PMC8955291/ /pubmed/35330108 http://dx.doi.org/10.3390/life12030357 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jakubec, Petr Fišerová, Kateřina Genzor, Samuel Kolář, Milan Pulmonary Complications after COVID-19 |
title | Pulmonary Complications after COVID-19 |
title_full | Pulmonary Complications after COVID-19 |
title_fullStr | Pulmonary Complications after COVID-19 |
title_full_unstemmed | Pulmonary Complications after COVID-19 |
title_short | Pulmonary Complications after COVID-19 |
title_sort | pulmonary complications after covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955291/ https://www.ncbi.nlm.nih.gov/pubmed/35330108 http://dx.doi.org/10.3390/life12030357 |
work_keys_str_mv | AT jakubecpetr pulmonarycomplicationsaftercovid19 AT fiserovakaterina pulmonarycomplicationsaftercovid19 AT genzorsamuel pulmonarycomplicationsaftercovid19 AT kolarmilan pulmonarycomplicationsaftercovid19 |